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Abstract 
 
Hydroxyapatite-based composites (HA-C) with bioglass as second phase are usually 
produced by hot-pressing or pressureless sintering. However, using such methods 
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thermal levels which exceed the crystallization temperature of the glass are generally 
required, with possible negative effects on the bioactivity of the final system. Spark plasma 
sintering (SPS) is a powerful consolidation technique in terms of both processing time and 
temperature. In this work SPS has been employed, for the first time, to obtain HA-C with 
an innovative bioglass as second phase. Such glass was specifically designed to be used 
whenever a thermal treatment is required, thanks to its low tendency to crystallize. A 
systematic study is conducted in order to identify the optimal sintering conditions for 
preparing highly dense composites and, at the same time, to minimize the crystallization 
of the glassy phase. The obtained samples are highly bioactive and display higher 
compactness and hardness with respect to the counterparts produced by conventional 
sintering methods. 
 
Keywords: Composites, Hydroxyapatite, Bioactive glasses, spark plasma sintering, 
Mechanical properties. 
 
1. Introduction 
The repair of osseous defects caused by tumors, traumatic events or inflammatory diseases 
is a common clinical problem. Current lines of treatment such as autogenous bone grafts, 
which involve the transplantation of bone from another part of the patient, or allografts, 
where bone tissue is taken from donors or cadavers, are affected by specific drawbacks, 
i.e., donor site morbidity, disease transmission risks, high costs and potential 
complications like infections [1, 2]. In the last 40 years several research works have been 
devoted to develop specific synthetic alternatives for the replacement of damaged or lost 
bones. In this context, hydroxyapatite (HA), which belongs to the calcium phosphates 
group, plays a prominent role in oral, maxillofacial and orthopaedic surgery since the 
1980s [3, 4]. Thanks to its similarity to the biological apatite, which constitutes the mineral 
phase of hard tissues, HA exhibits excellent biocompatibility and osteoconductivity, as it is 
able to promote, in vivo, bone tissue apposition to its surface. HA has been extensively 
used in form of cements, powders and granules to produce bone fillers and synthetic bone 
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grafts for biomedical applications. Unfortunately, the poor mechanical performance of HA 
(in particular the tensile strength and fracture toughness) makes its use difficult in bulk 
form when load bearing capacity is required. As a consequence, for such applications, HA 
utilization is mainly confined to the deposition of bioactive coatings on metallic implants 
[5 – 8].  
The disadvantages associated to the use of HA also include the high sintering 
temperatures typically required for obtaining bulk products [9, 10]; moreover, the 
reactivity of this material at body temperature and physiological pH is typically low, 
consequently the osseointegration rate of HA-based grafts, which should match the rate of 
growth of the new tissue, is also rather modest [7, 11]. This fact can be particularly 
detrimental for the production of HA scaffolds for bone tissue engineering, which should 
resorb in a predictable way, at the same rate as the tissue is repaired.  
In order to overcome these limitations, several investigations have been addressed 
to the preparation of HA-based composites with bioactive glasses as second phase. Most 
of these studies involved the use of 45S5 Bioglass® (45S5), the first bioactive glass 
developed by Larry Hench in 1969 [12]. 45S5 is a degradable glass in the Na2O–CaO–SiO2–
P2O5 system, and it is able to form a chemical bond with soft tissues as well as with bone. 
In general, bioactive glasses bond to bone more rapidly than other bioceramics. Moreover, 
in vitro studies demonstrated that the dissolution products (e.g. Si, P, Ca) of 45S5 stimulate 
osteoblasts proliferation and seem to induce angiogenesis and neo-vascularization [13]. 
The production of HA/bioactive glass composites opens intriguing scenarios, since 
it allows to go beyond the intrinsic limits of the ceramic and glassy phases when 
considered singularly [4]. On the one hand, by varying the volume fractions of the two 
constituents, it is possible to control the bioactivity and the dissolution rate of the resulting 
material, so that innovative systems with tailored biological properties can be obtained. In 
addition, the use of glasses may be further exploited to incorporate specific ions, such as 
fluorine, silicon, magnesium or strontium, within the lattice of HA, with the aim to 
reproduce the composition of the biological apatite, which is intrinsically 
nonstoichiometric and calcium-deficient with many di- and tri-valent ion substitutions 
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[14]. Furthermore, the glass may act as sintering aid, thus promoting the densification of 
the composite powders [9, 10].  
One of the main issues concerning the production of HA/bioactive glasses 
composites regards the thermal treatment which is necessary to sinter them. The 
densification of 45S5-based composites by pressureless sintering usually requires 
temperatures up to 1300 °C, which exceeds the crystallization temperature of the glassy 
phase. On the one hand, the crystallization of the glass has an adverse effect on the 
sintering process, thus limiting the densification of the final system which may be prone to 
unwanted residual porosity. Moreover, the HA decomposition and/or reactions between 
glass and apatite during the thermal treatment was also observed. Finally, the 
crystallization of the glassy phase may reduce its bioactivity [3, 9, 10, 15]. 
Several investigations have been devoted to understand how to tailor the glass 
formulation with the aim to prevent crystallization [16–18]. In recent years, a novel class of 
silicate glasses with lower tendency to crystallize with respect to 45S5 were produced and 
employed to develop HA-based composites. In particular the so-called BG_Ca/Mix system 
– a CaO-rich, K2O modified glass composition – was specifically formulated as an 
alternative to 45S5 to be used whenever thermal treatments on bioactive glasses are 
required [19, 20]. A crystallization temperature of 880 °C is reported for BG_Ca/Mix, while 
45S5 starts to crystallize at temperatures as low as 610 °C [21]. BG_Ca/Mix powders were 
recently used to produce various HA-based composites containing up to 70 wt.% of HA 
[22, 23]. Although it was possible to sinter the novel samples at a lower temperature with 
respect to HA/45S5 composites with the same HA/glass proportion, the composites with 
higher amounts of HA suffered for some residual porosity and poor mechanical 
properties. For these reasons, several efforts have been made to identify more efficient 
powder densification techniques, as an alternative to classical sintering.  
In this regard, spark plasma sintering (SPS), also referred to as pulsed electric 
current sintering (PECS) or field-assisted sintering technique (FAST), represents a more 
effective consolidation method with respect to conventional pressureless and hot-pressing 
approaches [24]. Briefly, during SPS, an electric current flows through the graphite mould 
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containing the processing powders, that are therefore heated very fast by Joule effect. The 
simultaneous application of a mechanical load allows for the rapid obtainment of highly 
dense samples. Compared to alternative sintering methods, SPS has two main advantages: 
firstly, it makes processing time significantly shorter; secondly, it requires relatively lower 
temperatures to reach high consolidation levels. Consequently, SPS is beneficial in 
sintering processes where crystallization phenomena, grain growth, and/or phases 
decomposition have to be avoided or minimized. 
Based on these considerations, two studies aimed to the consolidation by SPS of 
three different commercial HA powders [25] as well as 45S5 and BG_Ca/Mix bioactive 
glasses [26] were recently carried out. In particular, the full densification of HA CAPTAL® 
powders was achieved after 5 min dwell time at 1200°C and the resulting product does not 
present any secondary phase [25]. Moreover, concerning the bioglass powders, completely 
dense and fully amorphous BG_Ca/Mix materials were produced by SPS at 730°C in 2 min 
holding time [26]. 
 In this work, the SPS technique is employed for the first time to produce HA-based 
composites with BG_Ca/Mix glass as second phase. Specifically, a systematic study is 
conducted to identify the optimal sintering conditions for preparing highly dense 
composites by considering three different HA/BG_Ca-Mix proportions. The obtained bulk 
products are then characterized from the compositional, microstructural and mechanical 
points of view. Finally, the bioactivity of the composites is investigated in vitro in a 
simulated body fluid solution. 
 
2. Materials and Methods 
2.1 Composites preparation 
The raw powder reagents (commercial SiO2, Na2CO3, CaCO3, K2CO3, Ca3(PO4)2 by Carlo 
Erba Reagenti, Rodano-Milano, Italy) were melted at 1450 °C for 1 hour to produce 
BG_Ca/Mix (composition: 47.3 mol% SiO2, 45.6 mol% CaO, 2.3 mol% K2O, 2.3 mol% Na2O, 
and 2.6 mol% P2O5). Subsequently the melt was quenched in room-temperature water to 
obtain a frit which was dried at 110 °C for 12 hours and then milled into powder (grain 
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size < 45 μm). BG_Ca/Mix and commercial HA powders (CAPTAL® Hydroxylapatite, 
Plasma Biotal Ltd, UK) were accurately mixed in a plastic bottle using a rolls shaker for 6 
hours in order to prepare the following set of composites: 
 80 wt.% BG Ca/Mix and 20 wt.% HA powders (“80BG_20HA”); 
 50 wt.% BG Ca/Mix and 50 wt.% HA powders (“50BG_50HA”); 
 30 wt.% BG Ca/Mix and 70 wt.% HA powders (“30BG_70HA”). 
Moreover, SPSed pure HA were prepared and subsequently used as a control in the 
investigation of the composites’ bioactivity (see next paragraphs). The sintering conditions 
for the production of the HA samples have been previously reported and discussed in Ref. 
[25].  
 
2.2 Spark plasma sintering of composite powders 
 
Spark plasma sintering Pulsed electric current sintering experiments for the 
consolidation of 80BG_20HA, 50BG_50HA and 30BG_70HA and 50BG_50HA powders 
were performed by means of a SPS 515S equipment (Fuji Electronic Industrial Co., Ltd., 
Japan), which is based on the combination of an uniaxial press (50 kN maximum load) 
with a DC pulsed current generator (10 V, 1500 A, 300 Hz). The 12:2 ON/OFF pulses 
sequence was adopted, with the characteristic time of each pulse of about 3.3 ms. About 
1.49, 1.53 or 1.56 g of 80BG_20HA, 50BG_50HA and 30BG_70HA powders, respectively, 
were placed in a cylindrical die (outside diameter of 35 mm, inside diameter of 15 mm, 
and 30 mm high) equipped with two punches. All the tooling components consisted of 
AT101 graphite (Atal s.r.l., Italy). To facilitate sample release after SPS, a graphite foil with 
a 0.13 mm thickness (Alfa Aesar Karlsruhe, Germany) was placed between the pressed 
powder and the die/plungers walls. In addition, the die was covered with a graphite felt 
layer (3 mm thick, Atal s.r.l., Italy) to minimize thermal losses during the heating process.  
Temperature measurement and control was performed using a K-type 
thermocouple (Omega Engineering Inc., USA) inserted in a small hole drilled at the die 
surface. The real-time evolution of a number of parameters, i.e., temperature, electric 
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current, voltage between the machine electrodes, applied load, and vertical sample 
displacement was recorded. It should be noted that the contribution of thermal expansion 
of the electrodes and graphite tooling has to be subtracted to the measured displacement 
to obtain sample shrinkage data () [27], which will be considered hereafter.  
During SPS runs, the temperature was first increased at a rate of 50°C/min until a 
value of 100°C lower than the holding temperature (TD) was achieved. Afterwards, the TD 
level was reached at a lower heating rate (10°C/min) to minimize overshooting problems. 
The effect of the dwell temperature was investigated in the range 730-1150°C. The sample 
was kept at the sintering temperature for a time interval (tD) varying from 3 sec to 10 min. 
The applied mechanical pressure was varied from 16 to 30 MPa. It should be noted that 
the sintering conditions adopted in the present work were selected based on the results 
recently obtained when the SPS apparatus was used to consolidate separately on the two 
separate composite constituents. In particular, the less severe conditions needed to obtain 
full dense HA and BG_Ca/Mix samples were 1200°C, 5 min and 30 MPa [25] and 730°C, 2 
min, and 16 MPa [26], respectively. 
Finally, sintered disks with diameter of 14.7 mm and thickness of about 3 mm were 
obtained. For the sake of reproducibility, each experiment was repeated at least twice. 
 Densities of polished SPSed samples were determined by the Archimedes method. 
The theoretical densities of the 80BG_20HA, 50BG_50HA and 30BG_70HA systems, i.e., 
2.915, 3.015 and 3.074 g/cm3, respectively, were calculated using a rule of mixture [28]. In 
this regard, a density values of 3.16 g/cm3 for HA and 2.86 g/cm3 for BG_Ca/Mix were 
considered.  
 Phase composition of differently sintered composites was determined by XRD 
analysis using a Philips PW 1830 X-rays diffractometer (Philips PW 1830, Almelo, The 
Netherlands) equipped with a Ni filtered Cu K radiation (=1.5405 Å). 
 
2.3. Microstructural and Mechanical characterization of the composites 
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Among the produced composites, a subset has been selected, based on high values 
of density, for further characterizations. The bulk products examined are listed in Table 1 
along with the corresponding SPS conditions and relative densities. 
The mirror polished cross-sections of the obtained samples were observed in an 
Environmental Scanning Electron Microscope (ESEM Quanta 2000, FEI Co., Eindhoven, 
The Netherland) operated in low-vacuum conditions (~0.5 Torr). Qualitative 
compositional analyses were performed by means of X-ray energy dispersion 
spectroscopy (X-EDS) (Inca, Oxford Instruments, UK). 
Vickers micro-indentation tests (Wolpert Group, Micro-Vickers Hardness Tester 
digital auto turret, Mod. 402MVD) were performed on the polished cross-sections in order 
to determine the Vickers hardness of the samples. For each material, at least 15 clear and 
crack-free indentations were performed by applying a maximum load of 100 gf for 15 s 
[29].  
 
2.4. Investigation of the in vitro bioactivity  
 
The in vitro bioactivity of the produced samples was evaluated by soaking them in 
an acellular simulated body fluid solution for different time periods, according to the 
procedure developed by Kokubo et al [30]. For each set of produced composites one 
sample was tested. The samples were soaked in flasks containing 25 ml of SBF and stored 
at  37 °C in an incubator. The solution was refreshed every about 48 hours. The contact 
between composites and the solution was interrupted after 3, 7 and 14 days. The 
specimens were then rinsed with water and left to dry for 24 hours at room temperature. 
The samples’ surface was observed by SEM in order to investigate microstructural changes 
that occurred after immersion and the possible precipitation of hydroxyapatite. Moreover, 
micro-Raman spectroscopy was performed, using a a Jobin–Yvon Raman Microscope 
spectrometer (Horiba Jobin–Yvon, Villeneuve D'ascq, France) equipped with a 632.8 nm-
wavelength He–Ne diode laser. 
 
3. Results and Discussion 
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3.1. Powders sintering  
 
The densification behaviour of the three composites produced under the same SPS 
conditions (TD=800°C, tD=10 min, P=30 MPa) is reported in Figure 1. The corresponding 
temperature profile is also shown. Similar gradual and modest changes of the  parameter 
are observed for the three composite powders when they are exposed to thermal levels 
below 700°C. On the other hand, as the temperature was further augmented, the sample 
shrinkage progressively increases at a higher rate, especially for the composite powders 
richer in BG_Ca/Mix. At the end of the experiments, the relative densities (average values) 
of the obtained sintered 80BG_20HA, 50BG_50HA and 30BG_70HA products were 98.075, 
88.4 and 73.8, respectively. These outcomes are perfectly consistent with the composition 
of the starting powders, i.e. sample density increases as the fraction of the constituent 
glass is progressively augmented. 
A systematic investigation was conducted to identify, for the three composites 
under consideration, the less severe SPS conditions able to guarantee the preparation of 
nearly full dense products. The results obtained for the 80BG_20HA system are shown in 
Figure 2(a). As expected, it is possible to notice that an increase of the holding 
temperature, dwell time and/or applied pressure parameters promotes powders 
consolidation, so that the conditions for producing samples having density higher than 
96% are identified. Specifically, such densification degree can be reached for TD values 
above 770°C when tD=10 min. As shown in Figure 2(b), the XRD pattern of the resulting 
product shows a broad hump, that evidences the still amorphous nature of BG_Ca/Mix, 
although the small peak of α-CaSiO3 provides an indication of the incipient crystallization 
of the bioglass. The latter phenomenon is significantly enhanced as the sintering 
temperature was increased to 800°C. Indeed, peaks intensity related to α-CaSiO3 increases 
markedly. In addition, a smaller amount of β-CaSiO3 was also found and, more important, 
the amorphous hump basically disappeared from the XRD pattern.  
Crystallization phenomena can be mitigated if the holding time is sufficiently 
shortened while maintaining the thermal levels unchanged. In fact, as reported in Figure 
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2(c), no additional crystalline phases, other than HA, are detected by XRD in the 95.7% 
dense product obtained by SPS after 3 sec at 780°C. However, a small amount of α-CaSiO3 
was formed when the temperature was raised to 800°C to improve powders densification 
up to 96.7%, considering the same tD and P conditions. Nonetheless, the XRD analysis 
revealed that in the latter case the sintered product still exhibits an amorphous character. 
In order to further increase the end product densities, higher temperatures or applied 
pressures were also considered. However, samples breakage correspondingly occurred 
during the SPS process. 
Based on the results described above, it is possible to state that TD=800°C, tD= 3 sec, 
and P=30 MPa are the more convenient SPS conditions, among those ones investigated in 
the present work, to produce 80BG_20HA samples with average densities higher than 
96.5%, where the crystallization of the bioglass is just at the early stage.  
Accordingly, the optimal holding temperature for the other two composite systems 
examined in this work was identified by setting the tD and P values equal to 3 sec and 30 
MPa, respectively.  
Specifically, the data obtained for the 50BG_50HA sample are plotted in Figure 3. 
As expected, due to the presence of a larger amount of HA, the consolidation of these 
powders required higher thermal levels with respect to the previous system. In particular, 
as reported in Figure 3(a), a 90.5% dense 50BG_50HA sample (average value) was 
produced by SPS when the holding temperature was set at 850°C. Under such conditions, 
no additional phases were evidenced by the XRD analysis. On the other hand, both α- and 
β-CaSiO3 were found in the slightly denser compacts obtained at 950°C (relative density of 
about 92.5%). In addition, it can be observed that a further temperature increase to 1000°C 
determined a partial transformation of α- to β- CaSiO3. A product approximately 98% 
dense was correspondingly obtained.  
Powder consolidation gets more difficult when the fraction of HA in the composite 
mixture is further increased, so that the occurrence of crystallization phenomena is 
favored by the higher TD values required to reach the desired densification levels. In 
particular, as reported in Figure 4(a), still very porous 30BG_70HA products resulted 
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when the holding temperature was set at 950°C. Moreover, as evidenced by the 
corresponding XRD pattern shown in Figure 4(b), such condition was anyway sufficient to 
determine a significant crystallization from the glassy phase with the formation of CaSiO3, 
in both the α- and β- forms. The progressive increase of the temperature strongly 
promoted powder consolidation, so that fully dense products are obtained at 1150°C.  
Based on the observed outcomes, the lowest holding temperatures, among those 
investigated, sufficient to reach a density of 96.5% or higher for 80BG_20HA, 50BG_50HA 
and 30BG_70HA specimens by SPS (tD= 3 sec, P= 30 MPa) are 800, 1000 and 1150°C, 
respectively.  
These findings are well in agreement with the results recently obtained when HA 
and BG_Ca/Mix powders were separately processed by SPS [25, 26]. First of all, the 
beneficial role played by the glass component as sintering aid is evidenced. Indeed, it was 
found that the SPS conditions needed for the nearly full consolidation of BG free HA were 
TD= 1200°C, tD= 5 min and P=30 MPa [25]. On the other hand, the same goal could be 
reached after only 3 sec at 1150°C or lower temperatures, when at least 30% of BG_Ca/Mix 
are added to the mixture. Moreover, based on XRD analysis, HA did not decompose when 
the three composites systems under investigation were processed by SPS. This is an 
important outcome, since the formation of -TCP or other secondary phases from the HA 
decomposition, which tends to occur in the powders undergoing SPS when operating at 
relatively higher temperatures, might reduce the bioactivity of the resulting sample. 
Indeed, recent studies evidenced that -TCP exhibits a rather lower aptitude, with respect 
to HA, to promote the formation of new phosphate phases in the bioceramic surface 
during both in vitro (simulated body fluid) and in vivo experiments [31]. 
As for the behavior of the BG_Ca/Mix constituent, it is observed that the massive 
composite samples with relative densities equal or higher than 96% are generally obtained 
in presence of a certain bioglass crystallization. The only exception is represented by the 
80BG_20HA system processed for 3 sec at 780°C. On the other hand, a slight temperature 
increase to 800°C produced, other than an improvement of powder densification, also the 
formation of a small amount of α-CaSiO3. This feature was relatively more accentuated 
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when the other two composites – richer in HA – were taken into account. The latter result 
is readily associated to the fact that, when the relative amount of HA in the composite is 
progressively augmented, the dwell temperatures set to consolidate powder mixtures 
have to be higher. In particular, the optimal TD values identified in this work to achieve 
density levels above 96% for the 80BG_20HA, 50BG_50HA and 30BG_70HA systems are 
800, 1000 and 1150°C, respectively. Therefore, the crystallization of the bioglass is 
correspondingly favoured, as clearly confirmed by the XRD analyses of the resulting 
sintered samples. In particular, the temperature levels up to 1150°C needed to obtain 
nearly full dense 30BG_70HA materials have further promoted the formation of CaSiO3, 
also in the β- configuration, from the glassy phase.  
Nonetheless, it should be noted that devitrification phenomena as well as HA 
decomposition would occur at a significant higher degree if classic sintering methods, less 
efficient than SPS, and/or other bioglass compositions, displaying higher tendency to 
crystallize with respect to BG_Ca/Mix, are used. 
 
3.2.  Microstructural and Mechanical characterization 
 
The bulk products examined by SEM are listed in Table 1 along with the 
corresponding SPS conditions and relative densities. Figure 5 and Figure 6 display some 
representative micrographs of the cross sections of the produced composites. Although the 
samples are adequately densified, some residual pores are still present. Nevertheless, 
several features visible in the sample images can be attributed to the preferential removal 
of HA-rich particles during the polishing step. This aspect is more evident when observing 
the micrograph of the 80BG_20HA#1 cross section reported in Figure 7(a) and the 
corresponding X-EDS maps, which show the distribution of P, representative of HA in the 
composite, and Si, associate to the glass. In fact, the damaged areas in Figure 7(a) can be 
mainly identified as HA, since they are particularly poor in Si and rich in P. Beside this 
feature, the cross section images show areas with different brightness (see, in particular, 
Figure 8): light areas should be ascribed to HA, while dark ones are representative of 
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BG_Ca/Mix. It should be noted that the 30BG_70HA#2 sample looks particularly compact, 
with no traces of porosities. This finding is quite interesting, since the counterparts 
produced by traditional sintering suffered from widespread residual porosity and poor 
mechanical performance [22, 23]. On the contrary, the SPS technique allowed to obtain 
fully dense and compact samples, regardless of the HA/glass proportions. This fact is 
further confirmed by the micro-hardness values of the produced samples, which are 
reported in Table 1. It should be stressed that a direct comparison between the mechanical 
performance of the produced composites is not straightforward, since the samples differ in 
composition, density, microstructure, degree of crystallization of the glassy phase and 
mechanical properties of the formed crystalline phases. Nonetheless, on the basis of 
previous results obtained in the literature on the same HA and bioglass systems processed 
either separately by SPS or in combination using a diverse sintering technique, some 
considerations can be made in this context. First of all, it is important to underline that the 
SPSed composites obtained in the present work show significantly higher hardness with 
respect to samples with the same HA/glass ratio prepared by traditional sintering. For 
sake of comparison, a Vickers hardness of 368.1 ± 83.3 is reported in Ref. [23] for 
80BG_20HA composites produced by means of traditional sintering. Furthermore, the 
residual porosity present in 30BG_70HA samples obtained using the latter approach did 
not permit the obtainment of reliable data for their micro-hardness [23]. In fact, 
indentation techniques are very sensitive to local defects, such as pores. It should be 
finally noted that 50BG_50HA counterparts have not been produced yet by conventional 
sintering. 
The results reported in Table 1 indicate that the 30BG_70HA_#2 samples, which are 
characterized by a particularly high compactness ( > 99.9%) and a defects-free 
microstructure (see Figures 6(f) and 8(a)), show the best performance also in terms of 
Vickers hardness. In contrast, the 30BG_70HA_#1 specimen has the lowest hardness 
among the samples examined in the present work. This result can be likely due to its lower 
density ( = 96.9%) and the relatively higher HA content. In this regard, it should be noted 
that two recent investigations focused on HA and BG_Ca/Mix processed separately by 
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SPS, revealed that the micro-hardness data for BG_Ca/Mix were slightly higher than those 
ones found for HA (see Ref. [25, 26] for details). Such finding is consistent to the lower 
hardness displayed by 30BG_70HA_#1 samples with respect to those ones obtained for 
80BG_20HA_#1 and 80BG_20HA_#3 specimens, which have the same density but are 
characterized by a higher BG_Ca/Mix content. The hardness of 50BG_50HA samples is 
rather similar to the 80BG_20HA ones, since the negative effect due to the lower 
BG_Ca/Mix fraction in the 50BG_50HA composite is probably counterbalanced by its 
relatively higher density ( = 98.6%). For what concerns the 80BG_20HA samples, the 
80BG_20HA_#3 has the best performance. However, in this case the analysis is 
complicated by the fact that the different degree of crystallization of BG_Ca/Mix in the 
composites should be taken in account. For example, the results reported in Figure 2 show 
that the amorphous nature of BG_Ca/Mix is better retained in 80BG_20HA#3 than in 
80BG_20HA#2, although the latter one is denser. This fact could explain the slightly higher 
hardness of 80BG_20HA#3 with respect to that of 80BG_20HA#2. 
 
3.3 In vitro bioactivity of the composites 
 
Since the SPS method has been used for the first time to produce the composite 
systems under consideration, some preliminary results relative to the evaluation of their 
bioactivity are also reported. In this regard, the reactivity of the samples was investigated 
in vitro according to the procedure by Kokubo et al [30]. This method, which aims to 
evaluate the apatite formation ability of bioactive glasses and bioceramics in SBF, is widely 
used as a preliminary screening test of the samples’ bioactivity.  
After soaking in SBF, the characterization of the produced composites revealed the 
formation of apatite precipitates, which progressively spread on the samples’ surface. In 
Figures 9 and 10 it is possible to observe that the 80BG_20HA#1 surface, after 7 and 14 
days of immersion, respectively, is covered by aggregates of spherical particles with the 
typical apatite morphology. The X-EDS analysis (Figure 9(b, c)) performed on the 
precipitates revealed that such aggregates are particularly rich in calcium and 
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phosphorous. Some Si is also detectable, due to the glassy phase underneath the 
precipitates  and to the possible formation of a silica gel layer, according to the models 
which describe the reaction mechanisms of bioceramics and bioactive glasses in SBF 
reported by the literature [12, 32, 33]. The nature of the globular precipitates was further 
investigated by micro-Raman spectroscopy. The Raman spectrum acquired on the 
80BG_20HA#1 composite after 14 days in SBF, which is shown in Figure 11, looks rather 
similar to that of commercial apatite [34]. It is possible to observe three peaks, i.e. an 
intense and sharp peak at ~960 cm−1 and two peaks with lower intensity at ~430 cm−1 and 
~590 cm−1, which are ascribable to the PO4 vibrations [35]; a further peak at ~1070 cm−1 can 
be referred to the stretching of carbonate groups [36]. In conclusion, it is possible to 
identify the precipitates on 80BG_20HA#1 as carbonated hydroxyapatite: this confirms the 
in vitro bioactivity of the prepared samples. Previous investigations have demonstrated 
that dense HA produced by SPS showed strong ability to induce hydroxyapatite formation 
in vitro [37, 38]. Nevertheless, it should be stressed that the development of such apatite 
layer on the composites under consideration could be mainly ascribable to BG_Ca/Mix, 
which revealed significantly higher in vitro reactivity. This fact is clearly evidenced in 
Figure 12, which shows the surfaces of SPSed bioglass-free HA, 30BG_70HA, 50BG_50HA 
and 80BG_20HA after soaking in SBF for three days. It is possible to observe that the 
relative content of apatite precipitates on the samples’ surface increased with the 
increasing amount of BG_Ca/Mix in the sample. In particular, the newly formed apatite 
completely covered the 80BG_20HA surface, i.e., the sample with the highest content of 
glass. Therefore, the addition of BG_Ca/Mix may be used to modify the dissolution of the 
final system and to tune its biological response to the specific clinical application. It should 
be stressed that the latter aspect probably represents the most important advantage 
associated to the use of silicate-glass/HA composites. Moreover, thanks to its low tendency 
to crystallize, the BG_Ca/Mix in the composites maintained almost completely its 
amorphous nature, with positive effects in terms of the resulting bioactivity; on the other 
hand, the partial crystallization of BG_Ca/Mix to α- and β-CaSiO3, which belong to the 
family of wollastonite ceramics, is not detrimental regarding the HA-forming ability in 
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SBF, since such crystalline phases also display a bioactive character, as reported in the 
literature [39–42]. For example, Liu et al., who investigated the bioactivity of wollastonite 
coatings deposited on titanium, observed the formation of hydroxycarbonate apatite on 
the coatings’ surface after 1 day in SBF [39]. A good bioactivity was also shown by dense 
β-CaSiO3 ceramics produced through SPS and subsequently tested in SBF for increasing 
soaking times [40]. The bioactivity in SBF of both α- and β-CaSiO3 has been confirmed by 
Siriphannon et al [41] who also discussed about the differences in vitro between the two 
phases. Finally, other studies demonstrated that α- and β-CaSiO3 ceramics are also able to 
support cell attachment, proliferation and differentiation [42].  
It is important to note that the findings concerning bioactivity of the obtained composites 
are qualitatively analogous to those ones reported for their counterparts produced by 
means of traditional sintering [22, 23]. However, the composites processed by SPS , in 
particular the 30BG_70HA and 50BG_50HA samples, exhibit far higher compactness, 
hardness and density. For these reasons, the SPS technology looks very promising for the 
production of HA/bioactive glass composites.  
 
4. Conclusions 
 
In this work SPS was employed to produce almost completely dense and highly 
bioactive composites based on different mixtures of HA and of BG_Ca/Mix, a recently 
developed CaO-rich silicate bioactive glass.  The produced samples are very compact and 
significantly denser ( ≥ 96%) with respect to the counterparts produced by conventional 
sintering methods. In particular, for the first time, a set of HA/BG_Ca-Mix samples 
(70wt.% HA) with a density near to the theoretical value has been successfully obtained. 
Furthermore, thanks to the low tendency to crystallize of the innovative BG_Ca/Mix, it 
was possible to reduce the devitrification of the glassy phase in the samples, with 
beneficial effects in terms of the resulting in vitro bioactivity. Although a certain degree of 
glass crystallization is typically observed in fully dense composite samples, crystallization 
phenomena, as well as HA/glass reactions and HA decomposition, are considerably lower 
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with respect to those observed when classic sintering methods and/or other bioactive glass 
compositions are used. In conclusion, (1) SPS provides an efficient tool to produce HA-
based composites with bioactive glass as second phase, and (2) BG_Ca/Mix is confirmed to 
be particularly useful whenever a thermal treatment is required to produce the final 
system. Further studies regarding the biocompatibility of the obtained samples as well as  
the production by SPS of HA/BG_Ca-Mix composites modified with ions of biological 
interest, such as strontium and/or magnesium, are under investigation. The results will be 
the subject of future works.  
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Table 1. Samples, processing parameters, final density and Vickers hardness of the 
produced composites. Vickers hardness is expressed as mean value ± standard deviation. 
For sake of comparison, in Ref [23] a hardness of 368.1 ± 83.3 Vickers is reported for 
80BG_20HA composites produced by means of traditional sintering.  
 
Sample TD, tD  [%] HV [Vickers] 
80BG_20HA_#1 770°C, 10 min 96.9 539.5 ± 31.1 
80BG_20HA_#2 800°C, 10 min 98.45 553.1 ± 25.4 
80BG_20HA_#3 800°C, 3 sec 96.9 586.4 ± 20.8 
50BG_50HA 1000°C, 3 sec 98.6 536.3 ± 29.7 
30BG_70HA_#1 1100°C, 3 sec 96.9 456.4 ± 38.2 
30BG_70HA_#2 1150°C, 3 sec >99.9 634.7 ± 19.9 
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Figure 1. Example of the temperature-time profile and the corresponding sample 
shrinkage curves obtained during the consolidation of the three composite systems by SPS 
(TD=800°C, tD=10 min, P=30 MPa). 
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Figure 2. Effect of the sintering conditions on the relative density (a) of 80BG_20HA 
samples produced by SPS and the corresponding XRD patterns obtained at P=30 MPa 
when tD=10 min (b) and tD= 3 sec (c). 
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Figure 3. Effect of the sintering temperature (tD= 3 sec, P=30 MPa) on the relative density 
(a) of 50BG_50HA samples produced by SPS and the corresponding XRD patterns (b). 
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Figure 4. Effect of the sintering temperature (tD= 3 sec, P=30 MPa) on the relative density 
(a) of 30BG_70HA samples produced by SPS and the corresponding XRD patterns (b). 
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Figure 5. Cross sections of the produced composites. 
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Figure 6. Cross sections of the produced composites: high magnification micrographs.  
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Figure 7. Micrograph of the 80BG_20HA#1 cross section (a) and corresponding X-EDS 
maps showing the distribution of Si (b) – representative of the glass – and P (c), 
representative of HA.  
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Figure 8. Micrograph of the 30BG_70HA#2 cross section (a) and results of the X-EDS 
analysis (b, c) performed on the areas indicated in (a). 
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Figure 9. Micrograph of the 80BG_20HA#1 surface after 7 days in SBF (a) and results of the 
X-EDS analysis (b, c) performed on the areas indicated in (a). 
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Figure 10. Micrograph of the 80BG_20HA#1 surface after 14 days in SBF. 
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Figure 11. Raman spectra acquired on the precipitates formed on the 80BG_20HA#1 
surface after 14 days in SBF. 
 
 
Figure 12. SEM images of the SPSed HA (a), 30BG_70HA#1 (b), 50BG_50HA (c) and 
80BG_20HA#1 (d) samples after 3 days in SBF. 
 
